Defining a complete response following neoadjuvant chemoradiotherapy for oesophageal cancer

被引：0
|
作者：
Donohoe, C. [1 ]
King, S. [1 ]
Reynolds, J. V. [1 ]
机构：
[1] St James Hosp, Dept Surg, Trinity Coll Dublin, Dublin 8, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2011年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5
引用
收藏
页码：S254 / S254
页数：1
相关论文
共 50 条
  • [41] Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
    Mikaela L. Garland
    Ryash Vather
    Noah Bunkley
    Maria Pearse
    Ian P. Bissett
    International Journal of Colorectal Disease, 2014, 29 : 301 - 307
  • [42] Machine Learning Based Prediction of Distant Metastasis in Rectal Cancer Patients with Complete Response following Neoadjuvant Chemoradiotherapy
    Ozden, G.
    Adli, M.
    Aktan, M.
    Gunes, S.
    Acikgoz, S. Gokhan
    Alkis, H.
    Tezcan, Y.
    Koc, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E330 - E330
  • [43] Anatomical distribution of residual cancer in patients with oesophageal squamous cell carcinoma who achieved clinically complete response after neoadjuvant chemoradiotherapy
    Chao, Yin-Kai
    Chuang, Wen-Yu
    Yeh, Chi-Ju
    Chang, Hsien-Kun
    Tseng, Chen-Kan
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 53 (01) : 201 - 208
  • [44] The impact of obesity on complete pathologic response to neoadjuvant chemoradiotherapy in rectal cancer patients
    Diaz, C.
    Calderillo, G.
    Marytere, H.
    Ruiz-Garcia, E.
    Manuel, F.
    Trejo, E.
    Horacio, L.
    Luis, A. J.
    Herrera, A.
    Meneses, A.
    Alejandro, P.
    ANNALS OF ONCOLOGY, 2016, 27 : 39 - 39
  • [45] "Watch and Wait" for complete clinical response after neoadjuvant chemoradiotherapy for rectal cancer
    Peacock, Oliver
    Chang, George J.
    MINERVA CHIRURGICA, 2019, 74 (06) : 481 - 495
  • [46] Factors Associated with Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
    Liu, J.
    Zeng, X.
    Zhou, X.
    Xu, Y.
    Gong, Y.
    Wang, J.
    Zou, B.
    Zhou, L.
    Lu, Y.
    Liu, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E55 - E55
  • [47] Clinicopathologic factors predicting complete pathological response to neoadjuvant chemoradiotherapy in esophageal cancer
    MacGuill, M.
    Mulligan, E.
    Ravi, N.
    Rowley, S.
    Byrne, P. J.
    Hollywood, D.
    Kennedy, J.
    Keeling, P. N.
    Reynolds, J. V.
    DISEASES OF THE ESOPHAGUS, 2006, 19 (04) : 273 - 276
  • [48] Patients' preferences for treatment after neoadjuvant chemoradiotherapy for oesophageal cancer
    Noordman, B. J.
    de Bekker-Grob, E. W.
    Coene, P. P. L. O.
    van der Harst, E.
    Lagarde, S. M.
    Shapiro, J.
    Wijnhoven, B. P. L.
    van Lanschot, J. J. B.
    BRITISH JOURNAL OF SURGERY, 2018, 105 (12) : 1630 - +
  • [49] The comparisons of neoadjuvant chemoimmunotherapy versus chemoradiotherapy for oesophageal squamous cancer
    Xiao, Xin
    Yang, Yu-Shang
    Zeng, Xiao-Xi
    Shang, Qi-Xin
    Luan, Si-Yuan
    Zhou, Jian-Feng
    Li, Xiao-Kun
    Fang, Pin-Hao
    Hu, Yang
    Chen, Long-Qi
    Yuan, Yong
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2022, 62 (01)
  • [50] Outcomes of oesophageal cancer treated with neoadjuvant compared with definitive chemoradiotherapy
    Wujanto, Caryn
    Tey, Jeremy
    Vellayappan, Balamurugan
    So, Jimmy
    Yong, Wei Peng
    Shabbir, Asim
    Tseng, Michelle
    Soon, Yu Yang
    Ho, Francis
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2021, 50 (07) : 536 - 547
12345